Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15793-31-4

Post Buying Request

15793-31-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • [1-(9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-1-oxopropan-2-yl] acetate

    Cas No: 15793-31-4

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier

15793-31-4 Usage

General Description

1-(9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-1-oxopropan-2-yl acetate, also known as the non-preferred name, is a chemical compound with a complex structure. It contains a cyclopenta[a]phenanthren-17-yl group, along with multiple hydroxy and methyl groups. In addition, it has an acetate and oxopropan-2-yl functional group attached to the cyclopenta[a]phenanthren-17-yl group. 1-(9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-1-oxopropan-2-yl acetate (non-preferred name) may have pharmaceutical or industrial applications, and its detailed chemical properties should be further investigated.

Check Digit Verification of cas no

The CAS Registry Mumber 15793-31-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,7,9 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 15793-31:
(7*1)+(6*5)+(5*7)+(4*9)+(3*3)+(2*3)+(1*1)=124
124 % 10 = 4
So 15793-31-4 is a valid CAS Registry Number.

15793-31-4Upstream product

15793-31-4Downstream Products

15793-31-4Relevant articles and documents

Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor

-

, (2008/06/13)

Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15793-31-4